«Prior research in the field has primarily focused on using knowledge from
tumor tissue sequencing to identify specific changes to look for in circulating tumor DNA.
Not exact matches
A
tissue slice, a
tumor biopsy, or a sample of a bacterial culture yields a
sequence representing the average of all of the cells within it, even though researchers know there can be tremendous variation between those cells.
Of the 104 screened patients, 102 enrolled with 91 (89 percent) having adequate
tumor tissue to complete
sequencing.
To illuminate the process, the Yale team
sequenced normal, primary, and metastatic
tumor tissue from multiple individuals, including subjects with a range of cancer types.
Investigators compared DNA from the liquid blood biopsies to DNA
tissue samples from the
tumor, using mate - pair
sequencing — an inexpensive whole exome
sequencing that can reveal genetic changes that contribute to
tumor growth.
NYGC computational biologists and members of the Simon Laboratory at The Rockefeller University discussed the possibility of using a series of computer algorithms to search for
sequence differences between the
tumor samples and samples of healthy liver
tissue.
«Our findings show that high - intensity circulating
tumor DNA
sequencing is possible and may provide invaluable information for clinical decision - making, potentially without any need for
tumor tissue samples,» said lead study author Pedram Razavi, MD, PhD, a medical oncologist and instructor in medicine at Memorial Sloan Kettering Cancer Center (MSK) in New York, NY.
Another collaboration was unfolding among the cancer geneticists,
sequencing experts, clinical researchers, and surgical oncologists at Johns Hopkins, MD Anderson, and Baylor College of Medicine to study 32 pairs of head and neck
tumor and normal
tissue samples by whole - exome
sequencing and validate the findings in an additional 88 samples.
Just as one can't truly identify somatic mutations in a
tumor tissue without a matched normal, it's nearly impossible to distinguish de novo mutations in a patient without
sequencing both of his or her parents.
Grandis and Garraway decided to study a University of Pittsburgh collection of 74 pairs of
tumor and normal
tissue samples using the Broad's capacity to perform whole - exome
sequencing.
Past genomic studies of cancer compared
sequencing data from patients» healthy
tissue and the same patients»
tumors.
Fluorescence in situ hybridization (FISH) was used to screen for the presence of XMRV genomic
sequences in formalin - fixed, paraffin - embedded (FFPE)
tissue sections from VP62 (2012) and 19 newly collected
tumors (a subset of the 39 individuals in the prospective study).
Mammary
tumor virus
sequences have not been detected in normal breast
tissue or other
tumors.